Higher free thyroxine levels are associated with all-cause mortality in euthyroid older men: The Health in Men Study

European Journal of Endocrinology

Volumn 169, Issue 4, 2013, Pages 401-408

  Yeap, Bu B ^a,b   Alfonso, Helman ^c   Hankey, Graeme J ^a   Flicker, Leon ^a,c   Golledge, Jonathan ^d   Norman, Paul E ^e   Chubb, S A Paul ^a,f  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b FREMANTLE HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d JAMES COOK UNIVERSITY   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; THYROTROPIN; THYROXINE;

AGED; ALL CAUSE MORTALITY; ARTICLE; AUSTRALIA; BODY MASS; COMORBIDITY; CREATININE BLOOD LEVEL; DYSLIPIDEMIA; EUTHYROIDISM; FREE THYROXINE INDEX; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SMOKING; WAIST HIP RATIO;

AGED; AGED, 80 AND OVER; AGING; ASYMPTOMATIC DISEASES; COMORBIDITY; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; INCIDENCE; LONGITUDINAL STUDIES; MALE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REFERENCE VALUES; RISK FACTORS; THYROID FUNCTION TESTS; THYROID GLAND; THYROTROPIN; THYROXINE;

EID: 84884898599     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0306     Document Type: Article

References (40)

1. Franklyn JA. The thyroid-too much and too little across the ages. The consequences of subclinical thyroid dysfunction. Clinical Endocrinology 2013 78 1-8. (doi:10.1111/cen.12011)
2. Biondi B & Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocrine Reviews 2008 29 76-131. (doi:10.1210/er.2006- 0043) (Pubitemid 351252748)
3. Collet T-H, Gussekloo J, Bauer DC, den Elzen WPJ, Cappola AR, Balmer P, Iervasi G, Asvold BO, Sgarbi JA, Volzke H et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Archives of Internal Medicine 2012 172 799-809. (doi:10.1001/archinternmed.2012.402)
4. Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, Cornuz J & Rodondi N. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Annals of Internal Medicine 2008 148 832-845. (doi:10.7326/0003-4819-148-11-200806030-00225) (Pubitemid 351786932)
5. Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, Asvold BO, Iervasi G, Imaizumi M, Collet TH et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. Journal of the American Medical Association 2010 304 1365-1374. (doi:10.1001/jama.2010.1361)
6. Gencer B, Collet T-H, Virgini V, Bauer DC, Gussekloo J, Cappola AR, Nanchen D, den Elzen WPJ, Balmer P, Luben RN et al. Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from six prospective cohorts. Circulation 2012 126 1040-1049. (doi:10.1161/CIRCULATIONAHA. 112.096024)
7. Cooper DS & Biondi B. Subclinical thyroid disease. Lancet 2012 379 1142-1154. (doi:10.1016/S0140-6736(11)60276-6)
8. Somwaru LL, Rariy CM, Arnold AM & Cappola AR. The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study. Journal of Clinical Endocrinology and Metabolism 2012 97 1962-1969. (doi:10.1210/jc.2011-3047)
9. Surks MI & Boucai L. Age-and race-based serum thyrotrophin reference limits. Journal of Clinical Endocrinology and Metabolism 2010 95 496-502. (doi:10.1210/jc.2009-1845)
10. Bremner AP, Feddema P, Leedman PJ, Brown SJ, Beilby JP, Lim EM, Wilson SG, O'Leary PC & Walsh JP. Age-related changes in thyroid function: a longitudinal study of a community-based cohort. Journal of Clinical Endocrinology and Metabolism 2012 97 1554-1562. (doi:10.1210/jc.2011-3020)
11. Waring AC, Arnold AM, Newman AB, Buzkova P, Hirsch C & Cappola AR. Longitudinal changes in thyroid function in the oldest old and survival: the Cardiovascular Health Study All-Stars Study. Journal of Clinical Endocrinology and Metabolism 2012 97 3944-3950. (doi:10.1210/jc.2012-2481)
12. Gammage MD, Parle JV, Holder RL, Roberts LM, Hobbs FD, Wilson S, Sheppard MC & Franklyn JA. Association between serum free thyroxine concentration and atrial fibrillation. Archives of Internal Medicine 2007 167 928-934. (doi:10.1001/archinte. 167.9.928) (Pubitemid 46762755)
13. Murphy E, Gluer CC, Reid DM, Felsenberg D, Roux C, Eastell R & Williams GR. Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women. Journal of Clinical Endocrinology and Metabolism 2011 95 3173-3181. (doi:10.1210/jc.2009-2630)
14. Yeap BB, Alfonso H, Chubb SAP, Puri G, Hankey GJ, Flicker L & Almeida OP. Higher free thyroxine levels predict increased incidence of dementia in older men. The Health In Men Study. Journal of Clinical Endocrinology and Metabolism 2012 97 E2230-E2237. (doi:10.1210/jc.2012-2108)
15. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frolich M & Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. Journal of the American Medical Association 2004 292 2591-2599. (doi:10.1001/jama.292.21.2591) (Pubitemid 39577515)
16. van den Beld AW, Visser TJ, Feelders RA, Grobbee DE & Lamberts SWJ. Thyroid hormone concentrations, disease, physical function, and mortality in elderly men. Journal of Clinical Endocrinology and Metabolism 2005 90 6403-6409. (doi:10.1210/jc.2005-0872) (Pubitemid 41759292)
17. Waring AC, Harrison S, Samuels MH, Ensrud KE, LeBlanc ES, Hoffman AR, Orwoll E, Fink HA, Barrett-Connor E & Bauer DC. Thyroid function and mortality in older men: a prospective study. Journal of Clinical Endocrinology and Metabolism 2012 97 862-870. (doi:10.1210/jc.2011-2684)
18. Norman PE, Flicker L, Almeida OP, Hankey GJ, Hyde Z & Jamrozik K. Cohort profile: the Health In Men Study (HIMS). International Journal of Epidemiology 2009 38 48-52. (doi:10.1093/ije/dyn041)
19. Charlson ME, Pompei P, Ales KL & MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 1987 40 373-383. (doi:10.1016/0021- 9681(87)90171-8) (Pubitemid 17055592)
20. Holman CD, Bass AJ, Rosman DL, Smith MB, Semmens JB, Glasson EJ, Brook EL, Trutwein B, Rouse IL, Watson CR et al. A decade of data linkage in Western Australia: strategic design, applications and benefits of theWA data linkage system. Australian Health Review 2008 32 766-777. (doi:10.1071/AH080766)
21. Yeap BB, Alfonso H, Chubb SA, Walsh JP, Hankey GJ, Almeida OP & Flicker L. Higher free thyroxine levels are associated with frailty in older men. The Health In Men Study. Clinical Endocrinology 2012 76 741-748. (doi:10.1111/j.1365-2265.2011.04290.x)
22. Li M, Eastman CJ, Waite KV, Ma G, Zacharin MR, Topliss DJ, Harding PE,Walsh JP,Ward LC, Mortimer RH et al. Are Australian children iodine deficient? Results of the Australian National Iodine Nutrition Study Medical Journal of Australia 2006 184 165-169.
23. Asvold BO, Bjoro T, Nilson TI, Gunnell D & Vatten LJ. Thyrotrophin levels and risk of fatal coronary heart disease. Archives of Internal Medicine 2008 168 855-860. (doi:10.1001/archinte.168.8.855) (Pubitemid 351620087)
24. Parle JV, Maisonneuve P, Sheppard MC, Boyle P & Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotrophin result: a 10-year cohort study. Lancet 2001 358 861-865. (doi:10.1016/S0140-6736 (01)06067-6) (Pubitemid 32900566)
25. Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP & Ladenson PW. Thyroid status, cardiovascular risk, and mortality in older adults. Journal of the American Medical Association 2006 295 1033-1041. (doi:10.1001/jama. 295.9.1033)
26. Rodondi N, Newman AB, Vittinghoff E, de Rekeneire N, Satterfield S, Harris TB & Bauer DC. Subclinical hypothyroidism and risk of heart failure, other cardiovascular events, and death. Archives of Internal Medicine 2005 165 2460-2466. (doi:10.1001/archinte.165.21.2460) (Pubitemid 41720006)
27. Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P & Michelangeli V. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Archives of Internal Medicine 2005 165 2467-2472. (doi:10.1001/archinte.165.21.2467) (Pubitemid 41720007)
28. Iervasi G, Molinaro S, Landi P, Taddei MC, Galli E, Mariani F, L'Abbate A & Pingitore A. Association between increased mortality and mild thyroid dysfunction in cardiac patients. Archives of Internal Medicine 2007 167 1526-1532. (doi:10.1001/archinte.167.14. 1526) (Pubitemid 47124183)
29. Boekholdt SM, Titan SM, Wiersinga W, Chatterjee K, Basart DC, Luben R, Wareham NJ & Khaw K-T. Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. Clinical Endocrinology 2010 72 404-410. (doi:10.1111/j.1365-2265.2009.03640.x)
30. Ittermann T, Haring R, Sauer S,Wallaschofski H, Dorr M, Nauck M & Volzke H. Decreased serum TSH levels are not associated with mortality in the adult northeast German population. European Journal of Endocrinology 2010 162 579-585. (doi:10.1530/EJE-09-0566)
31. Sgarbi JA, Matsumura LK, Kasamatsu TS, Ferreira SR & Maciel RM. Subclinical thyroid dysfunctions are independent risk factors for mortality in a 7.5 year follow-up: the Japanese-Brazilian thyroid study. European Journal of Endocrinology 2010 162 569-577. (doi:10.1530/EJE-09-0845)
32. De Jongh RT, Lips P, van Schoor NM, Rijs KJ, Deeg DJ, Comijs HC, Kramer MH, Vandenbroucke JP & Dekkers OM. Endogenous subclinical thyroid disorders, physical and cognitive function, depression and mortality in older individuals. European Journal of Endocrinology 2011 165 545-554. (doi:10.1530/EJE-11-0430)
33. Hyland KA, Arnold AM, Lee JS & Cappola AR. Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study. Journal of Clinical Endocrinology and Metabolism 2013 98 533-540. (doi:10.1210/jc.2012-2180)
34. Razvi S, Shakoor A, Vanderpump M, Weaver JU & Pearce SH. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. Journal of Clinical Endocrinology and Metabolism 2008 93 2998-3007. (doi:10.1210/jc.2008-0167)
35. Barr EL, Tonkin AM, Welborn TA & Shaw JE. Validity of selfreported cardiovascular disease events in comparison to medical record adjudication and a statewide hospital morbidity database: the AusDiab Study. Internal Medicine Journal 2009 39 49-53. (doi:10.1111/j.1445-5994.2008.01864.x)
36. Hawkins RC. Furosemide interference in newer free thyroxine assays. Clinical Chemistry 1998 44 2550-2551. (Pubitemid 28565673)
37. Roos A, Bakker SJ, Links TP, Gans RO & Wolffenbuttel BH. Thyroid function is associated with components of the metabolic function in euthyroid subjects. Journal of Clinical Endocrinology and Metabolism 2007 92 491-496. (doi:10.1210/jc.2006-1718)
38. Garduno-Garcia Jde J, Alvirde-Garcia U, Lopez-Carrasco G, Mendoza MEP, Mehta R, Arellano-Campos O, Choza R, Sauque L, Garay-Sevilla ME et al. TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. European Journal of Endocrinology 2010 163 273-278. (doi:10.1530/EJE-10-0312)
39. Klein I & Danzi S. Thyroid disease and the heart. Circulation 2007 116 1725-1735. (doi:10.1161/CIRCULATIONAHA.106.678326) (Pubitemid 47537847)
40. Cooper C, Dere W, Evans W, Kanis JA, Rizzoli R, Sayer AA, Sieber CC, Kaufman J-M, Van Kan GA, Boonen S et al. Frailty and sarcopenia: definitions and outcome parameters. Osteoporosis International 2012 23 1839-1848. (doi:10.1007/s00198-012-1913-1)